Literature DB >> 32025816

How long should patients be surveyed for gastric cancer risk after Helicobacter pylori eradication therapy? 10 years is no longer enough.

Mitsushige Sugimoto1,2, Masaki Murata3,4, Takashi Kawai5.   

Abstract

Entities:  

Year:  2020        PMID： 32025816     DOI： 10.1007/s00535-020-01674-y

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  11 in total

1.  Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality.

Authors:  Jae Kwan Jun; Kui Son Choi; Hoo-Yeon Lee; Mina Suh; Boyoung Park; Seung Hoon Song; Kyu Won Jung; Chan Wha Lee; Il Ju Choi; Eun-Cheol Park; Dukhyoung Lee
Journal:  Gastroenterology       Date:  2017-01-29       Impact factor: 22.682

2.  Expression of angiotensin II type 1 and type 2 receptor mRNAs in the gastric mucosa of Helicobacter pylori-infected Mongolian gerbils.

Authors:  Mitsushige Sugimoto; Tomoyuki Ohno; Yoshio Yamaoka
Journal:  J Gastroenterol       Date:  2011-07-13       Impact factor: 7.527

3.  Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

Authors:  P Malfertheiner; F Megraud; C A O'Morain; J P Gisbert; E J Kuipers; A T Axon; F Bazzoli; A Gasbarrini; J Atherton; D Y Graham; R Hunt; P Moayyedi; T Rokkas; M Rugge; M Selgrad; S Suerbaum; K Sugano; E M El-Omar
Journal:  Gut       Date:  2016-10-05       Impact factor: 23.059

4.  Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH.

Authors:  Y Yamaoka; H M El-Zimaity; O Gutierrez; N Figura; J G Kim; T Kodama; K Kashima; D Y Graham; J K Kim
Journal:  Gastroenterology       Date:  1999-08       Impact factor: 22.682

5.  Gastric mucosal interleukin-17 and -18 mRNA expression in Helicobacter pylori-induced Mongolian gerbils.

Authors:  Mitsushige Sugimoto; Tomoyuki Ohno; David Y Graham; Yoshio Yamaoka
Journal:  Cancer Sci       Date:  2009-07-21       Impact factor: 6.716

6.  Effect of Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors: a meta-analysis.

Authors:  Seung Bae Yoon; Jae Myung Park; Chul-Hyun Lim; Yu Kyung Cho; Myung-Gyu Choi
Journal:  Helicobacter       Date:  2014-08       Impact factor: 5.753

7.  Helicobacter pylori status and risks of metachronous recurrence after endoscopic resection of early gastric cancer: a systematic review and meta-analysis.

Authors:  Shiyu Xiao; Sizhu Li; Liya Zhou; Wenjun Jiang; Jinzhe Liu
Journal:  J Gastroenterol       Date:  2018-09-24       Impact factor: 7.527

8.  Effect of Helicobacter pylori eradication on the incidence of gastric cancer: a systematic review and meta-analysis.

Authors:  Kentaro Sugano
Journal:  Gastric Cancer       Date:  2018-09-11       Impact factor: 7.370

9.  Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan.

Authors:  Momoko Tsuda; Masahiro Asaka; Mototsugu Kato; Rumiko Matsushima; Kenji Fujimori; Kozo Akino; Shogo Kikuchi; Yingsong Lin; Naoya Sakamoto
Journal:  Helicobacter       Date:  2017-08-03       Impact factor: 5.753

10.  Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication.

Authors:  Susumu Take; Motowo Mizuno; Kuniharu Ishiki; Chiaki Kusumoto; Takayuki Imada; Fumihiro Hamada; Tomowo Yoshida; Kenji Yokota; Toshiharu Mitsuhashi; Hiroyuki Okada
Journal:  J Gastroenterol       Date:  2019-10-30       Impact factor: 7.527
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.